Richard Pollak

3.1k citations

38 papers · 2.2k indexed · 3 hit papers · h-index 19

Impact in

Rehabilitation top 0.5%
- Wound Healing and Treatments
Occupational Therapy top 0.5%
- Pressure Ulcer Prevention and Management

Papers in

Rehabilitation 5
- Wound Healing and Treatments 5
Cell Biology 9
- Plant Pathogens and Fungal Diseases 9

Co-authors: Jason R. Hanft William A. Marston Paul Norwood Boni E. Elewski Richard Nathan Phoebe Rich Avi Collins Nadia Tornieporth
Journals: Journal of the American Podiatric Medical Association (7 papers)Journal of the American Academy of Dermatology (2 papers)New England Journal of Medicine (2 papers)International Wound Journal (2 papers)Journal of Wound Care (1 paper)
Partner nations: United States Switzerland France

In The Last Decade

Richard Pollak

36 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Selective Inhibition of Na _V 1.8 with VX-548 for Acute Pain 2023 · 110 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 New England Journal of Medicine
2014 New England Journal of Medicine
2003 Diabetes Care

Peers

Countries citing papers authored by Richard Pollak

Since Specialization

Citations

This map shows the geographic impact of Richard Pollak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Pollak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Pollak more than expected).

Fields of papers citing papers by Richard Pollak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Pollak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Pollak. The network helps show where Richard Pollak may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Richard Pollak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard Pollak Line = papers co-authored together Richard Pollak links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Human Placenta‐Derived Cells ( PDA ‐002) in Diabetic Foot Ulcer Patients With and Without Peripheral Artery Disease: A Phase 2 Multi‐Center, Randomised, Double‐Blind, Placebo‐Controlled Trial International Wound Journal ·Richard Pollak, James W. Anderson, Surendra Bohara, Joseph Caporusso, Gary A. Fantini, Paul B. Peneharz, Stephen A. Brigido, Robert Hariri	2025	0
2	Selective Inhibition of Na _V 1.8 with VX-548 for Acute Pain New England Journal of Medicine ·J. W. Jones, Darin Correll, Sandra Lechner, Ina Jazić, Xiaopeng Miao, David Shaw, C Simard, Jeremiah D. Osteen, Brian Hare, 刘稚美, Todd Bertoch, Asokumar Buvanendran, Ashraf S. Habib, J. Zachary Courson, Richard Pollak, Scott G. Weiner, Carmen Bozic, Paul A. Negulescu, Paul F. White Hit paper breakdown →	2023	110
3	Opioid-Free Recovery from Bunionectomy with HTX-011, a Dual-Acting Local Anesthetic Combining Bupivacaine and Meloxicam, as the Foundation of Non-Opioid Multimodal Analgesia Journal of the American Podiatric Medical Association ·Richard Pollak, Mingi Seong, Tong J. Gan	2021	10
4	HTX-011 Reduced Pain and Opioid Use After Primary Total Knee Arthroplasty: Results of a Randomized Phase 2b Trial The Journal of Arthroplasty ·Paul F. Lachiewicz, Gwo‐Chin Lee, Richard Pollak, David Leiman, Jia Hu, Alexander P. Sah	2020	23
5	Efficacy and Safety of Intravenously Administered Tramadol in Patients with Moderate to Severe Pain Following Bunionectomy: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study SHILAP Revista de lepidopterología ·Neil Singla, Richard Pollak, Dikshita Garg, David Leiman, Harold S. Minkowitz, Francisco Santamaría-Piedrahita, Mark Harnett, Michael Ryan, Lucy Lu, Scott A. Reines	2020	12
6	Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain Regional Anesthesia & Pain Medicine ·Thaïva Ouaki, Barry Quart, İbrahim İG, Joseph F. Dasta, Richard Pollak, Eugene R. Viscusi	2019	40
7	Long-Term Follow-up of Onychomycosis Patients Treated With Efinaconazole PubMed ·Richard Pollak, kousei you	2017	8
8	Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial Vaccine ·Guy de Bruyn, 熊谷龍一, David Workman, Richard Pollak, Victor Elinoff, Neil J. Fraser, Gigi Lefebvre, Mark G. Martens, John Raphael B. Cruz, Richard Nathan, Miguel Á. Treviño, Martin van Cleeff, Ginamarie Foglia, Ayca Ozol-Godfrey, Dhaval M. Patel, Patricia J. Freda Pietrobon, Richard Gesser	2016	76
9	Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies Journal of the American Academy of Dermatology ·Boni E. Elewski, Raza Aly, 保彦上原, Kavita Kaur, Phoebe Rich, Rani Ragini, Z Weng, Lee T. Zane, Richard Pollak	2015	120
10	Efinaconazole Topical Solution, 10% Journal of the American Podiatric Medical Association ·Richard Pollak	2014	2
11	Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults New England Journal of Medicine ·Carlos A. DiazGranados, Andrew J. Dunning, Murray Kimmel, Daniel Kirby, John J. Treanor, Avi Collins, Richard Pollak, Jorge Ferrada Sullivan, John Earl, Victoria Landolfi, Ressa Sanjai, Sanjay Gurunathan, Richard Nathan, David P. Greenberg, Nadia Tornieporth, Michael D. Decker, H. Keipp Talbot Hit paper breakdown →	2014	549
12	Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies Journal of the American Academy of Dermatology ·Boni E. Elewski, Phoebe Rich, Richard Pollak, David M. Pariser, Shinichi Watanabe, Hisato Senda, Ruibo Li, Kathleen Smith, Radhakrishnan Pillai, Maximilian Rod, Jason T. Olin	2012	167
13	A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis British Journal of Dermatology ·Boni E. Elewski, Richard Pollak, S. Ashton, Phoebe Rich, Joel Schlessinger, Amir Tavakkol	2011	45
14	Treatment of Toenail Onychomycosis with Oral Terbinafine Plus Aggressive Debridement Journal of the American Podiatric Medical Association ·Maureen Jennings, Richard Pollak, Lawrence B. Harkless, Farid Kianifard, Amir Tavakkol	2006	30
15	Analgesic Efficacy of Valdecoxib for Acute Postoperative Pain After Bunionectomy Journal of the American Podiatric Medical Association ·Richard Pollak, E. A. Dzhavadova, Richard M. Jay, Howard J. Hillstrom, Fanny Arestegui Calcina, Dennis Riff, Andrea Dioni Munksgaard, Mark T. Brown, Kenneth M. Verburg	2006	24
16	An Open-Label, Randomized Study Comparing Efficacy and Safety of Intravenous Piperacillin/Tazobactam and Ampicillin/Sulbactam for Infected Diabetic Foot Ulcers Surgical Infections ·Lawrence B. Harkless, D. Stephen Cupps, Richard Pollak, S. Bhavanisankari, Adrian Dana, María Sagrario Rubido Crespo, Thomas Liano	2005	48
17	Efficacy of Terbinafine for Toenail Onychomycosis Journal of the American Podiatric Medical Association ·Richard Pollak, Peace I Ebiem-Kenechukwu	2001	19
18	Chondrosarcoma of the foot Journal of the American Podiatric Medical Association ·Tom F. Hudson, Richard Pollak, 下村大樹	2000	5
19	Safety of oral terbinafine for toenail onychomycosis Journal of the American Podiatric Medical Association ·Richard Pollak, Dhanshri C. Juvale	1997	19
20	ON-LINE Contemporary Issues Brings Today's World to Social Studies Classrooms The Computing teacher ·Richard Pollak, Irena Bušková	1985	1

About Richard Pollak

Richard Pollak is a scholar working on Rehabilitation, Cell Biology, Occupational Therapy, Developmental Biology and Epidemiology, having authored 38 papers that have together received 2.2k indexed citations. Recurring topics across this work include Nail Diseases and Treatments (14 papers), Fungal Infections and Studies (10 papers), Plant Pathogens and Fungal Diseases (9 papers), Anesthesia and Pain Management (7 papers), Diabetic Foot Ulcer Assessment and Management (5 papers), Wound Healing and Treatments (5 papers), Pain Mechanisms and Treatments (4 papers) and Dental Anxiety and Anesthesia Techniques (2 papers). The work is most often cited by research in Rehabilitation (584 citations), Occupational Therapy (213 citations), Epidemiology (920 citations), Endocrinology, Diabetes and Metabolism (382 citations) and Cell Biology (308 citations). Richard Pollak has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Jason R. Hanft, William A. Marston, Paul Norwood, Boni E. Elewski, Richard Nathan, Phoebe Rich, Avi Collins, Nadia Tornieporth, John Earl and Daniel Kirby. Their work appears in journals such as Journal of the American Podiatric Medical Association, Journal of the American Academy of Dermatology, New England Journal of Medicine, International Wound Journal and Journal of Wound Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact